Maurice Lutgens

1.8k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Maurice Lutgens is a scholar working on Genetics, Oncology and Epidemiology. According to data from OpenAlex, Maurice Lutgens has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Maurice Lutgens's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (13 papers) and Colorectal Cancer Screening and Detection (12 papers). Maurice Lutgens is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (13 papers) and Colorectal Cancer Screening and Detection (12 papers). Maurice Lutgens collaborates with scholars based in Netherlands, Germany and United States. Maurice Lutgens's co-authors include Bas Oldenburg, Peter D. Siersema, Frank P. Vleggaar, Geert J. M. G. van der Heijden, Martijn G.H. van Oijen, Frank P. Vleggaar, Ad A. van Bodegraven, C. Janneke van der Woude, Dirk J. de Jong and Pieter Stokkers and has published in prestigious journals such as Gastroenterology, Gut and British Journal of Cancer.

In The Last Decade

Maurice Lutgens

26 papers receiving 1.0k citations

Hit Papers

Declining Risk of Colorectal Cancer in Inflammatory Bowel... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease
    2013 371 citations Maurice Lutgens, Martijn G.H. van Oijen et al. Inflammatory Bowel Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurice Lutgens Netherlands 12 733 551 373 295 143 26 1.1k
Krzysztof Grzyb Norway 17 307 0.4× 294 0.5× 334 0.9× 405 1.4× 184 1.3× 30 933
Romain Altwegg France 12 486 0.7× 385 0.7× 117 0.3× 202 0.7× 91 0.6× 63 735
Gui Han Lee United Kingdom 13 306 0.4× 231 0.4× 458 1.2× 226 0.8× 44 0.3× 18 974
S N Gyde United Kingdom 10 873 1.2× 647 1.2× 460 1.2× 421 1.4× 92 0.6× 14 1.2k
Lauranne Derikx Netherlands 15 459 0.6× 353 0.6× 175 0.5× 180 0.6× 27 0.2× 38 758
Joseph Loane United Kingdom 11 209 0.3× 231 0.4× 184 0.5× 123 0.4× 56 0.4× 19 609
Ingalill Friis–Liby Sweden 10 964 1.3× 1.1k 2.0× 78 0.2× 448 1.5× 397 2.8× 12 1.4k
Liesbeth Lemmens Belgium 11 550 0.8× 420 0.8× 100 0.3× 219 0.7× 69 0.5× 21 895
Eric S. Goldstein United States 10 416 0.6× 322 0.6× 199 0.5× 200 0.7× 26 0.2× 14 658
Kitaro Futami Japan 20 423 0.6× 275 0.5× 198 0.5× 422 1.4× 12 0.1× 58 807

Countries citing papers authored by Maurice Lutgens

Since Specialization
Citations

This map shows the geographic impact of Maurice Lutgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Lutgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Lutgens more than expected).

Fields of papers citing papers by Maurice Lutgens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Lutgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Lutgens. The network helps show where Maurice Lutgens may publish in the future.

Co-authorship network of co-authors of Maurice Lutgens

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice Lutgens. A scholar is included among the top collaborators of Maurice Lutgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice Lutgens. Maurice Lutgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fidder, Herma H., Bas Oldenburg, Janani Sundaresan, et al.. (2023). Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 58(11-12). 1151–1162. 13 indexed citations
3.
4.
Pierik, Marieke, Andrea E. van der Meulen‐de Jong, K Linde, et al.. (2021). Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients. Crohn s & Colitis 360. 4(3). otab001–otab001. 1 indexed citations
5.
Lutgens, Maurice, et al.. (2021). Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives. European Journal of Internal Medicine. 93. 35–41. 31 indexed citations
6.
Peters, Yonne, et al.. (2021). Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment. Inflammatory Bowel Diseases. 28(7). 1053–1060. 3 indexed citations
7.
Jong, Michiel E. de, et al.. (2020). Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology. 160(5). 1584–1598. 149 indexed citations
8.
Tan, Adriaan C.I.T.L., Maurice Lutgens, Lennard P. L. Gilissen, et al.. (2020). P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar. Journal of Crohn s and Colitis. 14(Supplement_1). S316–S317. 3 indexed citations
9.
Lutgens, Maurice, Martijn van Oijen, Erik Mooiweer, et al.. (2014). A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines. Gastrointestinal Endoscopy. 80(5). 842–848. 14 indexed citations
10.
Lutgens, Maurice, Séverine Vermeire, Martijn van Oijen, et al.. (2014). A Rule for Determining Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 13(1). 148–154.e1. 28 indexed citations
11.
Lutgens, Maurice, Martijn G.H. van Oijen, Geert J. M. G. van der Heijden, et al.. (2013). Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(4). 789–799. 371 indexed citations breakdown →
12.
Lutgens, Maurice, et al.. (2012). Risk Factors for Rectal Stump Cancer in Inflammatory Bowel Disease. Diseases of the Colon & Rectum. 55(2). 191–196. 13 indexed citations
13.
Mooiweer, Erik, Judith E. Baars, Maurice Lutgens, et al.. (2011). Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series. Journal of Crohn s and Colitis. 6(4). 435–440. 11 indexed citations
14.
Lutgens, Maurice, Peter D. Siersema, Frank P. Vleggaar, et al.. (2011). Risk Factors for Advanced Neoplasia of the Rectal Stump in IBD Patients. Gastroenterology. 140(5). S–351. 3 indexed citations
15.
Lutgens, Maurice, Peter D. Siersema, Frank P. Vleggaar, et al.. (2011). Different Risk Factors for Colitis Associated Colorectal Cancer in Ulcerative Colitis and Crohn's Disease. Gastroenterology. 140(5). S–351. 2 indexed citations
16.
Claessen, Marian M., Maurice Lutgens, Henk R. van Buuren, et al.. (2009). More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflammatory Bowel Diseases. 15(9). 1331–1336. 94 indexed citations
17.
Lutgens, Maurice, Peter D. Siersema, Ad A. van Bodegraven, et al.. (2009). Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. British Journal of Cancer. 101(10). 1671–1675. 113 indexed citations
18.
Lutgens, Maurice, Frank P. Vleggaar, M.E.I. Schipper, et al.. (2008). High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 57(9). 1246–1251. 153 indexed citations
19.
Vleggaar, F.P., Maurice Lutgens, Bas Oldenburg, M.E.I. Schipper, & Melvin Samsom. (2007). [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].. PubMed. 151(50). 2787–91. 5 indexed citations
20.
Vleggaar, Frank P., Maurice Lutgens, & Marian M. Claessen. (2007). Review article: the relevance of surveillance endoscopy in long‐lasting inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 26(s2). 47–52. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krzysztof Grzyb Breakdown of academic impact, for papers by Romain Altwegg Breakdown of academic impact, for papers by Gui Han Lee Breakdown of academic impact, for papers by S N Gyde Breakdown of academic impact, for papers by Lauranne Derikx Breakdown of academic impact, for papers by Joseph Loane Breakdown of academic impact, for papers by Ingalill Friis–Liby Breakdown of academic impact, for papers by Liesbeth Lemmens Breakdown of academic impact, for papers by Eric S. Goldstein Breakdown of academic impact, for papers by Kitaro Futami
Rankless by CCL
2026